RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
74 hedge funds and large institutions have $463M invested in Revance Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
91% less call options, than puts
Call options by funds: $16K | Put options by funds: $178K
Holders
74
Holding in Top 10
2
Calls
$16K
Puts
$178K
Top Buyers
| 1 | +$2.48M | |
| 2 | +$2.45M | |
| 3 | +$2M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$1.32M |
| 5 |
PC
PointState Capital
New York
|
+$1.22M |
Top Sellers
| 1 | -$3.17M | |
| 2 | -$1.97M | |
| 3 | -$1.36M | |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$1.28M |
| 5 |
SCM
Suffolk Capital Management
New York
|
-$1.1M |